Chris Roberts
Executive EditorMJBiz DailyChris has covered cannabis since spending a few months in Humboldt County in 2009, with bylines in The Guardian, VICE, Daily Beast, SF Weekly, Forbes.com, Leafly and many others. He won an investigative reporting award for a Curbed SF series revealing fraud at a radioactive U.S. Navy shipyard in San Francisco. He lives in New York City.
Hemp at the Cliff: Survive the Coming Enforcement Deadline
The hemp industry is approaching a challenging regulatory path. Pending federal and state enforcement deadlines aim to close the loophole that let in
The hemp industry is approaching a challenging regulatory path. Pending federal and state enforcement deadlines aim to close the loophole that let intoxicating, hemp-derived products flourish, redefining legal hemp by total-THC content rather than d
The hemp industry is approaching a challenging regulatory path. Pending federal and state enforcement deadlines aim to close the loophole that let intoxicating, hemp-derived products flourish, redefining legal hemp by total-THC content rather than delta-9 alone. For cultivators, retailers, and legal professionals, the stakes are immediate: products that pass today could be illegal overnight, stranding inventory and exposing operators to real lia
The hemp industry is approaching a challenging regulatory path. Pending federal and state enforcement deadlines aim to close the loophole that let intoxicating, hemp-derived products flourish, redefining legal hemp by total-THC content rather than delta-9 alone. For cultivators, retailers, and legal professionals, the stakes are immediate: products that pass today could be illegal overnight, stranding inventory and exposing operators to real liability.
This session offers a perspective of what the cliff actually means for your business. The panelists will break down total-THC compliance challenges and tightening synthetic cannabinoid restrictions, then pinpoint the categories most exposed, including delta-8, THCA flower, and high-potency THC beverages. Grounded in current hemp industry trends and cannabis business compliance realities, this discussion moves past speculation to give you a defensible plan. You'll leave knowing how to pivot, protect margin, and turn disruption into cannabis industry opportunities before your competitors react.
Solving for Schedule III: What Rescheduling Means for Operators
Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise
Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise with a clear-eyed look at what a move to Schedule III genuinely changes for cannabis businesses, an
Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise with a clear-eyed look at what a move to Schedule III genuinely changes for cannabis businesses, and what stays the same.
The panelists will unpack the regulatory issues that hit your bottom line. They'll examine Section 280E tax implications, shifting banking access, DEA oversight, and FDA comp
Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise with a clear-eyed look at what a move to Schedule III genuinely changes for cannabis businesses, and what stays the same.
The panelists will unpack the regulatory issues that hit your bottom line. They'll examine Section 280E tax implications, shifting banking access, DEA oversight, and FDA compliance requirements, with an honest assessment of timelines and open questions. Rather than chase headlines, the panelists will focus on the practical realities shaping cannabis market trends and the opportunities ahead.
